Pediatric nasopharyngeal carcinoma: Better prognosis and increased c-Kit expression as compared to adults

Pediatric Blood and Cancer

Volumn 45, Issue 3, 2005, Pages 291-297

  Bar Sela, Gil ^a,b   Arush, Myriam Weyl Ben ^a   Sabo, Edmond ^a   Kuten, Abraham ^a   Minkov, Ira ^a   Ben Izhak, Ofer ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Bcl 2; c Kit; Ki67; p53; Pediatric nasopharyngeal carcinoma

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; STEM CELL FACTOR; VIRUS RNA;

ADOLESCENT; ADULT; ADVANCED CANCER; AGE; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SCHOOL CHILD; SURVIVAL RATE; TISSUE SECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; FEMALE; HUMANS; ISRAEL; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-KIT; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 23044486594     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20264     Document Type: Review

References (30)

1. Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal cancer treated during 1976-1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-270.
2. Ingersoll L, Woo SY, Donaldson S, et al. Nasopharyngeal carcinoma in the young: A combined MD Anderson and Stanford experience. Int J Radiat Oncol Biol Phys 1990;4:881-887.
3. Kuten A, Cohen Y, Lavie R, et al. Update on nasopharyngeal carcinoma in northern Israel. Strahlenther Onkol 1994;170:565-570.
4. Zheng Z, Hu L, Chen F, et al. Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Oral Oncol, Eur J Cancer 1994;30:290-295.
5. Sheu LF, Chen A, Meng CL, et al. Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia and nasopharyngeal carcinoma: Association with p53 expression. Hum Pathol 1997;28:556-562.
6. Masuda M, Shinokuma A, Hirakawa N, et al. Expression of bcl-2, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment. Head Neck 1998;20:640-644.
7. Shnayder Y, Kuriakose MA, Yee H, et al. Adhesion molecules as prognostic factors in nasopharyngeal carcinoma. Laryngoscope 2001;111:1842-1846.
8. Preciado MV, Chabay PA, De Matteo EN, et al. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: Its correlation with p53 and bcl-2 expression. Med Pediatr Oncol 2002;38:345-348.
9. Rubio L, Burgos JS, Lopez-Guerrero JA, et al. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients. Pathol Res Pract 2002;198:97-102.
10. Shi W, Pataki I, MacMillan C, et al. Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer 2002; 94:1997-2006.
11. Wu TC, Mann RB, Epstein JI, et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma: A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol 1991;138:1461-1469.
12. Rodrigues NR, Rowan A, Smith ME, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-7559.
13. Miettinen M, Lasota J. Gastrointestinal stromal tumors: Definition clinical histological immunohistochemical and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1-12.
14. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-Kit gene product (CD117) in human tissues. Value in the diagnosis of mast cell disorders. Hum Pathol 1998;28:498-504.
15. Bokemeyer C, Kuczyk MA, Dunn T, et al. Expression of stem-cell factor and its receptor c-Kit protein in normal testicular tissues and malignant germ-cell tumours. J Cancer Res Clin Oncol 1996;122: 301-306.
16. Bar-Sela G, Kuten A, Ben-Eliezer S, et al. The expression of HER2 and c-Kit in nasopharyngeal carcinoma: Implications for a new therapeutic approach. Mod Pathol 2003;16:1035-1040.
17. Ayan I, Kaytan E, Ayan H. Childhood nasopharyngeal carcinoma: From biology to treatment. Lancet Oncol 2003;4:13-21.
18. Pathmanathan R, Prasad U, Sadler R, et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-698.
19. Tsai S-T, Jin Y-T, Su I-J. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization: A correlation with WHO histologic subtypes. Cancer 1996;77:231-236.
20. Smithey BE, Pappo AS, Hill DA. c-Kit expression in pediatric solid tumors: A comparative immunohistochemical study. Am J Surg Pathol 2002;26:486-492.
21. Vitali R, Cesi V, Nicotra MR, et al. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. Int J Cancer 2003;106: 147-152.
22. Roychowdhury DF, Tseng A, Jr., Fu KK, et al. New prognostic factors in nasopharyngeal carcinoma: Tumor angiogenesis and C-erbB2 expression. Cancer 1996;77:1419-1426.
23. Sheu LF, Chen A, Tseng HH, et al. Assessment of p53 expression in nasopharyngeal carcinoma. Hum Pathol 1995;26:380-386.
24. Murono S, Yoshizaki T, Park C-S, et al. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma. Histopathology 1999;34: 432-438.
25. Sahraoui S, Acharki A, Benider A, et al. Nasopharyngeal carcinoma in children under 15 years of age: A retrospective review of 65 patients. Ann Oncol 1999;10:1499-1502.
26. Ayan I, Altun M. Nasopharyngeal carcinoma in children: Retrospective review of 50 patients. Int J Radiat Oncol Biol Phys 1996;35:485-492.
27. Berberoglu S, Ilhan I, Cetindag F, et al. Nasopharyngeal carcinoma in Turkish children: Review of 33 cases. Pediatr Hematol Oncol 2001;18:309-315.
28. Uzel O, Yoruk SO, Sahinler I, et al. Nasopharyngeal carcinoma in childhood: Long-term results of 32 patients. Radiother Oncol 2001;58:137-141.
29. Erkal HS, Serin M, Cakmak A. Nasopharyngeal carcinomas: Analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol 2001;58:247-256.
30. Hoppe RT, Williams J, Warnke R, et al. Carcinoma of the nasopharynx-The significance of histology. Int J Radiat Oncol Biol Phys 1978;4:199-205.